Marine Drugs (Dec 2012)

Isolation, Characterization, and Bioactivity Evaluation of 3-((6-Methylpyrazin-2-yl)methyl)-1H-indole, a New Alkaloid from a Deep-Sea-Derived Actinomycete Serinicoccus profundi sp. nov.

  • Yong-Hong Liu,
  • Andre Steinmetz,
  • Xue-Feng Zhou,
  • Bing Yang,
  • Jian-Xi Ying,
  • Gai-Yun Zhang,
  • Xian-Wen Yang,
  • Ning Wang

DOI
https://doi.org/10.3390/md11010033
Journal volume & issue
Vol. 11, no. 1
pp. 33 – 39

Abstract

Read online

One new alkaloid, 3-((6-methylpyrazin-2-yl)methyl)-1H-indole (1) was obtained from the deep-sea actinomycete Serinicoccus profundi sp. nov., along with five known compounds (2–6). Their structures were determined on the basis of detailed analysis of the 1D and 2D NMR as well as MS data. The new indole alkaloid displayed weak antimicrobial activity against Staphylococcus aureus ATCC 25923 with an MIC value of 96 μg/mL. It showed no cytotoxicity on a normal human liver cell line (BEL7402) and a human liver tumor cell line (HL-7702).

Keywords